EANS-News: Marseille-Kliniken AG / Resolutions of extraordinary general meeting support the strategic reorientation of Marseille-Kliniken AG

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Annual & Special Corporate Meetings/Results Extraordinary General
Meeting

Hamburg, Germany (euro adhoc) - 19 October 2012 - The extraordinary
general meeting of Marseille-Kliniken AG held today at its
headquarter in Hamburg approved all applications introduced by the
company's administration with a majority of more than 99 percent. The
attending shareholders represented more than 67 percent of the share
capital.

With the approved shift from Regulated Market (Prime Standard) to
Entry Standard as part of the Open Market at the Frankfurt Stock
Exchange, Marseille-Kliniken AG consistently resumes its strategic
reorientation and internal reorganization. The change reflects the
company's recent development, as it owns a much leaner competitive
position after the business segments rehabilitation and acute care
have been disinvested or abandoned according to plan. Therefore the
Entry Standard appears to be the appropriate listing segment. The
principal stock market listing in Frankfurt and the respective
trading hours will however remain unchanged.

The company's streamlining is furthermore represented by an approved
amendment of the statutes for a future reduction of the supervisory
board from previously six to than three members. In this context
following the extraordinary general meeting today Messrs Uwe Bergheim
and Prof. Dr. med. Matthias P. Schönermark have already announced
their intention to resign from office after the end of the annual
general meeting which is planned for 3 December 2012. Another
amendment of the statutes builds furthermore the basis for a future
adjustment and new regulation of the compensation for the members of
the supervisory board.

Michael Thanheiser, chairman of Marseille-Kliniken AG, comments on
the resolutions of the extraordinary general meeting as follows: "We
wanted to give our shareholders the possibility to decide for their
own about the adequate listing segment. The clear vote for the shift
to Entry Standard is consistent with our company's recent
development, as our strategic reorientation aims at streamlining the
business and realising increases in efficiency. The same applies for
the reduction of the supervisory board. Both resolutions of our
shareholders are therefore also a confirmation of our corporate
strategy."

-- End of Corporate News ---

About Marseille-Kliniken AG:

Marseille-Kliniken AG (ISIN DE0007783003, WKN 778300, MKA) with its
57 residential care facilities, three residential units for assisted
living and about 4,700 employees is a market leading listed company
on health care in Germany. The business model is significantly
influenced by the demographic development. Therefore
Marseille-Kliniken AG has a secured future. Short-term economic
fluctuations on the other hand exert only a minor influence. As a
consistently modern company with strong focus on quality, the private
enterprise is in a good position within a competitive environment
primarily characterized by regionally active charities.

Further inquiry note:
Hillermann Consulting
Jan Pahl
Investor Relations for Marseille-Kliniken AG
Poststraße 14-16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 3202791-0
www.marseille-kliniken.de

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Marseille-Kliniken AG
Alte Jakobstraße 79/80
D-10179 Berlin
phone: +49 (0)30 246 32-400
FAX: +49 (0)30 246 32-401
mail: info@marseille-kliniken.de
WWW: http://www.marseille-kliniken.de
sector: Pharmaceuticals
ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
Hamburg, regulated dealing/prime standard: Frankfurt
language: English